Approval · Notice of Compliance 23113 · 2020
CEPHALEXIN: Notice of Compliance 23113
Issued January 16, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23113
- Date
- January 16, 2020
- Company
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Labelling Only
- Reason
- New labelling. licensing agreement between two companies
- Canadian reference product
- APO-CEPHALEX (Apotex Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CEPHALEXIN | 02495651 | Marketed |
Medicinal ingredients
- CEPHALEXIN MONOHYDRATE 500 MG per TAB